ALK-Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous ThromboembolismAlona Zer, Frances A. Shepherd, Ludmila Fridel et al.|Clinical Lung Cancer|2016Cited by 100
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)Elizabeth Dudnik, Nir Peled, Maya Ilouze et al.|Lung Cancer|2018Cited by 75